Global Urinalysis Test Market

Urinalysis Test Market Size, Share, Growth Analysis, By Application(Disease Screening, Pregnancy and Fertility), By End User(Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute), By Test(Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2324 | Region: Global | Published Date: April, 2024
Pages: 220 | Tables: 89 | Figures: 71

Urinalysis Test Market Insights

Global Urinalysis Test Market size was valued at USD 2.14 billion in 2022, USD 2.24 billion in 2023 and is projected to grow USD 3.09 billion by 2031, growing at a CAGR of 4.7% in the forecast period (2024-2031).

The market for urinalysis tests is made possible by growth and advancements in the medical equipment sector, which produces items for pregnancy testing and urinalysis, such as urine analyzers. Due to the availability of improved healthcare infrastructure, an increase in unmet healthcare needs, the rise in the prevalence of chronic diseases like diabetes, and a surge in demand for urine analyzers, strips, and control solutions, the urine test market is expected to grow at a rapid pace in untapped, emerging markets. As a result, the growing number of diabetics has raised demand for urine tests, driving the market's expansion.

Governments also conduct screening programmes to help discover diseases like renal and urological issues early. For example, the National Institute of Health (NIH) reports that 12,497 schoolchildren from Pingyang, Cangnan, and Yongjia in Wenzhou had urine screening between February 2012 and March 2021. As a result, it is anticipated that an increase in these programmes will fuel the market for urine tests. One of the most prevalent types of illnesses, urinary tract infections can affect both men and women. The need for urinalysis testing is being driven by the rising incidence of urinary tract infections, which are used to identify diabetes, various renal problems, and other conditions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Urinalysis Test Market size was valued at USD 2.14 billion in 2022, USD 2.24 billion in 2023 and is projected to grow USD 3.09 billion by 2031, growing at a CAGR of 4.7% in the forecast period (2024-2031).

Within the highly competitive urinalysis test market, several multinational corporations hold a dominant position by providing an extensive array of cutting-edge goods and solutions. Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens Healthineers, and Sysmex Corporation are important participants. To be competitive and fulfil the changing needs of customers and healthcare providers around the globe, these organisations concentrate on R&D, strategic alliances, and geographic expansion. 'Cardinal Health (US)', 'General Electric Company (US)', 'Metropolis India (India) ', '77 Elektronika Kft (Hungary)', 'Roche Diagnostics (Switzerland) ', 'Thermo Fisher Scientific (US)', 'Sysmex Corporation (Japan)', 'Abbott (US)', 'Trinity Biotech (Ireland)', 'ARKRAY Inc. (Japan)', 'Dr Lal PathLabs (India) ', 'F. Hoffmann-La Roche Ltd (Switzerland)', ' Siemens (Germany)', 'Sysmex Corporation (Japan)', 'BioMaxima SA (Poland)'

Rising urinary tract infection (UTI) rates in developing economies are one of the main factors driving the market ahead. Urinary tract infections (UTIs) have the potential to create complications during childbirth and extend to the kidneys if treatment is not received, which could drive market expansion.

Revolutionizing Urinalysis: The development of diagnostic technology is one of the most significant advances in urine analysis testing. The results of urinalysis are getting better thanks to automated urine analyzers and smartphone-based testing devices. Both patients and medical professionals may now test more easily and simply thanks to these developments. Urinalysis tests become more and more necessary as chronic conditions like diabetes and renal disease progress. The market is growing as urinalysis is useful for treating and keeping track of these conditions. In today's healthcare, urinalysis is essential since it can identify health problems early.

The market for urinalysis tests is dominated by North America due to the rise in chronic kidney and liver illnesses as well as diabetes. During the projected period, the expansion of the urinalysis test market in the area would be further aided by technological advancements. In North America, diabetes is a common chronic illness that is linked to aberrant urine composition. The urinalysis test market is expected to grow significantly in Asia-Pacific because of local enterprises increased technical advancements. The presence of medical equipment businesses in the region and the rise in the purchasing power of populous nations like China and India are responsible for the market's expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Urinalysis Test Market

Report ID: SQMIG35I2324

$5,300
BUY NOW GET FREE SAMPLE